                               SEQUENCE LISTING

<110> CENTRILLION TECHNOLOGY HOLDINGS CORPORATION
 
<120> PROBE INVERSION PROCESS FOR IN SITU SYNTHESIZED PROBE ARRAYS

<130> 38558-711.602

<140>
<141>

<150> 62/293,203
<151> 2016-02-09

<150> 62/206,741
<151> 2015-08-18

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
ggctgagtat gtggtctat                                                    19


<210> 2
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
cgaacgacgc aatagaccac atactcagcc                                        30


<210> 3
<211> 16
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
tcgatgcaag cttgca                                                       16


<210> 4
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (17)..(18)
<223> a, c, t, g, unknown or other

<400> 4
ggctgagtat gtggtcnnt                                                    19


<210> 5
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 5
cgaacgacgc aatagaccac atactcagcc                                        30


<210> 6
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> modified_base
<222> (18)..(19)
<223> a, c, t, g, unknown or other

<400> 6
ggctgagtat gtggtctnn                                                    19


